The full story behind the headlines.
Three times his research did not just inform a decision. It changed the call. Here is what was at stake, what he did, and what moved.
The bet he stopped before it shipped
Olympus was advancing a major investment in tablet-based, nurse-assisted clinical reporting. The thesis looked sound on paper, and momentum was building behind it.
Leading the research function he had built, Norman ran studies that put the workflow in front of the people who would actually use it, surfacing limitations and patient-safety concerns that the original thesis had missed.
The findings led the team to drop the tablet approach and pivot to an intraprocedural, AI-powered ambient voice solution, protecting patient safety and the budget at the same time.
The assumption that was quietly costing growth
A sophisticated, demanding brand team held firm assumptions about Pure Leaf's premium positioning. They already had strong consumer insight and high standards for the research they would trust.
Norman led authentic consumer ethnography, going deeper than the usual in-home interviews to uncover how people actually related to the category, then communicated the findings with clarity and persuasion.
The work helped reshape packaging and messaging strategy and contributed to Pure Leaf becoming one of PepsiCo's fastest-growing beverage brands.
The belief that was capping the market
WHOOP held a long-standing assumption about who its product was for, one that quietly limited how the company thought about its addressable market and its pricing.
Norman led mixed-methods research and conjoint pricing work that challenged the assumption directly, identifying an unmet need among broader health-focused consumers and pressure-testing the subscription model.
The research contributed to a new feature, an expanded addressable market, and an overhaul of the subscription model and pricing structure.